When did Idexx Laboratories report Q2 2025 earnings?

Idexx Laboratories (IDXX) reported Q2 2025 earnings on August 4, 2025 before market open.

What were Idexx Laboratories's Q2 2025 revenue and EPS?

Idexx Laboratories reported revenue of $1.1B and diluted EPS of $3.63 for Q2 2025.

Did Idexx Laboratories beat estimates in Q2 2025?

Revenue beat the consensus estimate of $1.1B by $47.1M. EPS beat the consensus estimate of $3.28 by $0.35.

How did Idexx Laboratories's Q2 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 10.6% from $1.0B a year earlier and diluted EPS grew 20.2% from $3.02.

Where can I find Idexx Laboratories's Q2 2025 SEC filings?

You can read the 10-Q periodic report (0000874716-25-000121) directly on SEC EDGAR. The filing index links above go to sec.gov.

Idexx Laboratories IDXX Q2 2025 earnings

Reported August 4, 2025 · Before market open

Revenue$1.1BBeat by $47.1M Diluted EPS$3.63Beat by $0.35

Revenue estimate$1.1B

EPS estimate$3.28

Next report

Aug 4, 2026 (In 3 weeks)

Revenue estimate$1.2B

EPS estimate$3.95

Financials

Q2 2025

Income statement

See full

Revenue$1.1B+10.6%

Gross profit$694.7M+12.2%

Operating income$373.0M+41.4%

Net income$294.0M+44.6%

EPS (diluted)$3.63+48.8%

Balance sheet

See full

Cash & equivalents$164.6M-59.0%

Total debt$658.3M-19.5%

Total equity$1.5B-7.7%

Total assets$3.3B-2.5%

Cash flow

See full

Operating cash flow$185.7M-25.2%

CapEx$34.1M+2.4%

Free cash flow$151.6M-29.5%

Valuation & ratios

Valuation

as of 06/30/25

See full

Market cap$42.66B+5.4%

Enterprise value$43.16B+5.5%

P/E43.3×-4.6×

P/S10.6×-0.1×

Profitability

See full

Gross margin61.5%+1.1pp

Operating margin31.1%+2.5pp

Net margin24.4%+2.1pp

FCF margin19.4%-2.7pp

Returns & leverage

See full

Return on equity64.9%+1.6pp

Debt / equity0.5×-0.1×

Current ratio1.1×-0.3×

Segments

By product

See full

IDEXX VetLab consumables$375.1M+15.3%

Reference laboratory diagnostic and consulting services$367.7M+5.8%

Rapid assay products$100.2M-3.0%

Recurring revenue$69.0M+9.2%

CAG Diagnostics capital - instruments$58.6M+66.0%

By segment

See full

Water segment revenue$51.0M+9.1%

LPD$31.8M+4.8%

Versus estimates

Revenue

Q1 2026$1.1BBeat by $22.3M Q4 2025$1.1BBeat by $17.9M Q3 2025$1.1BBeat by $32.0M

Q2 2025$1.1BBeat by $47.1M

Q1 2025$998.4MBeat by $1.3M Q4 2024$954.3MBeat by $19.1M

Diluted EPS

Q1 2026$3.47Beat by $0.06 Q4 2025$3.08Beat by $0.15 Q3 2025$3.40Beat by $0.26

Q2 2025$3.63Beat by $0.35

Q1 2025$2.96Beat by $0.11 Q4 2024$2.62Beat by $0.23

Ask the moment Idexx Laboratories reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Idexx Laboratories report Q2 2025 earnings?: Idexx Laboratories (IDXX) reported Q2 2025 earnings on August 4, 2025 before market open.
What were Idexx Laboratories's Q2 2025 revenue and EPS?: Idexx Laboratories reported revenue of $1.1B and diluted EPS of $3.63 for Q2 2025.
Did Idexx Laboratories beat estimates in Q2 2025?: Revenue beat the consensus estimate of $1.1B by $47.1M. EPS beat the consensus estimate of $3.28 by $0.35.
How did Idexx Laboratories's Q2 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue grew 10.6% from $1.0B a year earlier and diluted EPS grew 20.2% from $3.02.
Where can I find Idexx Laboratories's Q2 2025 SEC filings?: You can read the 10-Q periodic report (0000874716-25-000121) directly on SEC EDGAR. The filing index links above go to sec.gov.